Market Cap 3.80M
Revenue (ttm) 0.00
Net Income (ttm) -18.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 139,400
Avg Vol 608,098
Day's Range N/A - N/A
Shares Out 2.94M
Stochastic %K 2%
Beta 2.72
Analysts Hold
Price Target $200.00

Latest News on CNSP

CNS Pharmaceuticals Announces Reverse Stock Split

Feb 19, 2025, 8:30 AM EST - 6 weeks ago

CNS Pharmaceuticals Announces Reverse Stock Split


CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 15, 2024, 9:10 AM EST - 4 months ago

CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results


CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

May 16, 2024, 7:45 AM EDT - 11 months ago

CNS Pharmaceuticals Reports First Quarter 2024 Financial Results


CNS Pharmaceuticals to Present at the LSX World Congress 2024

Apr 23, 2024, 9:00 AM EDT - 1 year ago

CNS Pharmaceuticals to Present at the LSX World Congress 2024